Kinder Morgan Stock Has 11% Upside, According to 1 Wall Street Analyst
Published
Despite a recent downgrade, the analyst still sees 11%-plus upside potential for the energy specialist.
Full ArticlePublished
Despite a recent downgrade, the analyst still sees 11%-plus upside potential for the energy specialist.
Full ArticleBiotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.
Will these catalysts be enough to support the stock's high valuation?